Effects of ARHI on cell cycle progression and apoptosis levels of breast cancer cells

The Expression and Clinical Significance of GTP-Binding RAS-Like 3 (ARHI) and MicroRNA 221 and 222 in Prostate Cancer

(2013) D Lin et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

(2011) Wieslawa H Dragowska et al.   BMC CANCER

Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy

(2011) Min-Yu Chen et al.   CANCER

HER-2 Positive and p53 Negative Breast Cancers are Associated With Poor Prognosis

(2011) Dhafir Al-azawi et al.   CANCER INVESTIGATION

Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism

(2011) Y. Zhao et al.   CANCER RESEARCH

Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1

(2011) Sharon B Cantor et al.   Future Oncology

IQGAP1 Protein Binds Human Epidermal Growth Factor Receptor 2 (HER2) and Modulates Trastuzumab Resistance

(2011) Colin D. White et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin–TGFβ signaling

(2011) P-K Lo et al.   ONCOGENE

The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways

(2011) D B Badgwell et al.   ONCOGENE

Targeting the Phosphatidylinositol 3-Kinase Signaling Pathway in Breast Cancer

(2011) L. F. Hernandez-Aya et al.   ONCOLOGIST

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer

(2011) Renaud Sabatier et al.   PLoS One

Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma

(2010) Xiaohai Zhao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

(2010) M Knauer et al.   BRITISH JOURNAL OF CANCER

A novel interaction between HER2/neu and cyclin E in breast cancer

(2010) E A Mittendorf et al.   ONCOGENE

Role of melatonin in the epigenetic regulation of breast cancer

(2008) Ahmet Korkmaz et al.   BREAST CANCER RESEARCH AND TREATMENT